These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23529447)

  • 1. Production and validation of recombinant adeno-associated virus for channelrhodopsin expression in neurons.
    Lin JY
    Methods Mol Biol; 2013; 998():401-15. PubMed ID: 23529447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic excitation of neurons with channelrhodopsins: light instrumentation, expression systems, and channelrhodopsin variants.
    Lin JY
    Prog Brain Res; 2012; 196():29-47. PubMed ID: 22341319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-efficiency transduction and specific expression of ChR2opt for optogenetic manipulation of primary cortical neurons mediated by recombinant adeno-associated viruses.
    Jin L; Lange W; Kempmann A; Maybeck V; Günther A; Gruteser N; Baumann A; Offenhäusser A
    J Biotechnol; 2016 Sep; 233():171-80. PubMed ID: 27416794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-amplification system for recombinant adeno-associated virus production.
    Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12).
    Paul D; Qazilbash MH; Song K; Xu H; Sinha BK; Liu J; Cowan KH
    Cancer Gene Ther; 2000 Feb; 7(2):308-15. PubMed ID: 10770641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus mediated expression of human erythropoietin in vitro.
    Diao Y; Xu RA; Wang GJ; Zhao XC
    Acta Pharmacol Sin; 2002 Jan; 23(1):55-8. PubMed ID: 11860738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current issues in adeno-associated viral vector production.
    Merten OW; Gény-Fiamma C; Douar AM
    Gene Ther; 2005 Oct; 12 Suppl 1():S51-61. PubMed ID: 16231056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production and purification of helper free recombinant adeno-associated virus 2].
    Li GL; Wang RZ; Wang X; Dou WC; Zhang B; Tian SQ; Ren ZY; Su CB
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1255-8. PubMed ID: 12930642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
    Shiau AL; Liu PS; Wu CL
    J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the commercial-scale production of adeno-associated viral vectors.
    Wilson JM
    Hum Gene Ther; 2009 Jul; 20(7):695. PubMed ID: 19848589
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
    Furler S; Paterna JC; Weibel M; Büeler H
    Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
    Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
    Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.
    McCarty DM; Fu H; Monahan PE; Toulson CE; Naik P; Samulski RJ
    Gene Ther; 2003 Dec; 10(26):2112-8. PubMed ID: 14625565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant adeno-associated virus vector related impurities].
    Diao Y; Wang Q; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of specific AAV serotypes to stably transduce primary CNS neuron cultures.
    Malik SZ; Maronski MA; Dichter MA; Watson DJ
    Methods Mol Biol; 2012; 846():305-19. PubMed ID: 22367821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant adeno-associated virus for skeletal gene therapy.
    Dai J; Rabie AB
    Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhancement of target gene expression by recombinant adeno-associated virus combined with recombinant adenovirus in vivo].
    Liu X; Li G; Li Q; Tian WD; Zhang W; Chen HH; Li XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):44-8. PubMed ID: 21269954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection and DNA-mediated gene transfer.
    Zecchin D; Di Nicolantonio F
    Methods Mol Biol; 2011; 731():435-50. PubMed ID: 21516427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
    Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
    Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.